Dr. Edmund Lattime, professor of surgery at UMDNJ Robert Wood Johnson Medical School, was named deputy director of The Cancer Institute of New Jersey (CINJ) by Dr. Joseph R. Bertino, interim director, CINJ.
Dr. Lattime joined CINJ in 1998 following faculty appointments first at Memorial Sloan Kettering and then at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia.
His laboratory and clinical studies focus on tumor immunology, gene therapy and the development of vaccines for cancer treatment. As deputy director, he will be responsible for continuing the development of the research programs at CINJ.
Dr. Junichi Sadoshima, professor and vice chair of cell biology and molecular medicine at UMDNJ New Jersey Medical School, and his group of researchers have identified a novel mechanism for controlling heart muscle growth. They have identified an antioxidant molecule that prevents the heart muscle from becoming unusually enlarged.
Findings from the study were published in the June 13 edition of Cell. According to Dr. Sadoshima, who is also associate director of the Cardiovascular Research Institute at the school, further research on the method to effectively deliver the antioxidant into heart cells could prove to be promising for patients who have enlarged hearts and heart failure.
New research findings from Dr. Lorna Rodriguez, chief of gynecologic oncology at The Cancer Institute of New Jersey and associate professor of obstetrics, gynecology and reproductive sciences at UMDNJ-Robert Wood Johnson Medical School, indicate the potential for more targeted treatment of ovarian cancer.
Currently, the standard of care involves the drugs carboplatin and paclitaxel, which have shown the ability to shrink ovarian cancer tumors; however, that shrinkage may not last for a long period due to the development of drug resistance. Previous data shows that selenium inhibits the development of a tumor’s resistance to carboplatin. The current study couples selenium with the two drugs with the goal of preventing or slowing drug resistance.
Two internationally recognized researchers from UMDNJ New Jersey Medical School were recently honored with the Medal of Excellence Award during the Annual Musical Moments for Multiple Sclerosis (MS) benefit concert at the New Jersey Performing Arts Center on June 5.
The honorees have something else in common: Dr. Teresa Wood and Dr. Steven Levison have the distinction of being one of the few husband-wife MS research teams in the United States. Dr. Wood is professor and Rena Warshow Chair in Multiple Sclerosis, and Dr. Levison is professor of Neurology and Neurosciences.
